FEATURED PRODUCTS

1600+ autoantigens

High-throughput quantitation of autoantibodies

200+ CT antigens

Quantification of autoantibodies to  clinically relevant CT antigens

100+ p53 variants

Simultaneous screening of 
wild-type and p53 mutants

15 COVID-19 epitopes

Multi-antigen, multi-epitope
COVID-19 Ab, nAb and aAb test

Our featured products can be easily ordered from any of the channels below:

WEBINARS

Register for our upcoming webinar and view our past webinars here

VIEW HERE

VIDEOS

Learn more about our products and their applications here

WATCH HERE

Member of Cancer, Inflammation & Immunity, and Neuroscience
Steering Committees:

Industrial Advisory Board Member:

Member:

TECHNOLOGY

KREX protein folding technology

PRODUCTS & SERVICES

List of products and services

CONTACT US

One technology - endless possibilities

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389